Copyright Reports & Markets. All rights reserved.

Global Small Molecule Targeted Drugs for Allergic Diseases Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Small Molecule Targeted Drugs for Allergic Diseases by Type
    • 1.3.1 Overview: Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Type in 2025
    • 1.3.3 JAK
    • 1.3.4 TYK2
  • 1.4 Global Small Molecule Targeted Drugs for Allergic Diseases Market by Application
    • 1.4.1 Overview: Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Atopic Dermatitis
    • 1.4.3 Asthma
    • 1.4.4 Others
  • 1.5 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size & Forecast
  • 1.6 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast by Region
    • 1.6.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region, (2021-2032)
    • 1.6.3 North America Small Molecule Targeted Drugs for Allergic Diseases Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size and Prospect (2021-2032)
    • 1.6.6 South America Small Molecule Targeted Drugs for Allergic Diseases Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 AbbVie
    • 2.1.1 AbbVie Details
    • 2.1.2 AbbVie Major Business
    • 2.1.3 AbbVie Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
    • 2.1.4 AbbVie Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AbbVie Recent Developments and Future Plans
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
    • 2.2.4 Pfizer Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Pfizer Recent Developments and Future Plans
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
    • 2.3.4 Novartis Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Novartis Recent Developments and Future Plans
  • 2.4 Eli Lilly and Company
    • 2.4.1 Eli Lilly and Company Details
    • 2.4.2 Eli Lilly and Company Major Business
    • 2.4.3 Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
    • 2.4.4 Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Eli Lilly and Company Recent Developments and Future Plans
  • 2.5 LEO Pharma
    • 2.5.1 LEO Pharma Details
    • 2.5.2 LEO Pharma Major Business
    • 2.5.3 LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
    • 2.5.4 LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 LEO Pharma Recent Developments and Future Plans
  • 2.6 AstraZeneca
    • 2.6.1 AstraZeneca Details
    • 2.6.2 AstraZeneca Major Business
    • 2.6.3 AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
    • 2.6.4 AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 AstraZeneca Recent Developments and Future Plans
  • 2.7 Incyte
    • 2.7.1 Incyte Details
    • 2.7.2 Incyte Major Business
    • 2.7.3 Incyte Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
    • 2.7.4 Incyte Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Incyte Recent Developments and Future Plans
  • 2.8 Jiangsu Hengrui Pharmaceuticals
    • 2.8.1 Jiangsu Hengrui Pharmaceuticals Details
    • 2.8.2 Jiangsu Hengrui Pharmaceuticals Major Business
    • 2.8.3 Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
    • 2.8.4 Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Jiangsu Hengrui Pharmaceuticals Recent Developments and Future Plans
  • 2.9 Suzhou Zelgen Biopharmaceuticals
    • 2.9.1 Suzhou Zelgen Biopharmaceuticals Details
    • 2.9.2 Suzhou Zelgen Biopharmaceuticals Major Business
    • 2.9.3 Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
    • 2.9.4 Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Suzhou Zelgen Biopharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Small Molecule Targeted Drugs for Allergic Diseases Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Small Molecule Targeted Drugs for Allergic Diseases by Company Revenue
    • 3.2.2 Top 3 Small Molecule Targeted Drugs for Allergic Diseases Players Market Share in 2025
    • 3.2.3 Top 6 Small Molecule Targeted Drugs for Allergic Diseases Players Market Share in 2025
  • 3.3 Small Molecule Targeted Drugs for Allergic Diseases Market: Overall Company Footprint Analysis
    • 3.3.1 Small Molecule Targeted Drugs for Allergic Diseases Market: Region Footprint
    • 3.3.2 Small Molecule Targeted Drugs for Allergic Diseases Market: Company Product Type Footprint
    • 3.3.3 Small Molecule Targeted Drugs for Allergic Diseases Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2021-2032)
  • 6.2 North America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2032)
  • 6.3 North America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country
    • 6.3.1 North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2021-2032)
    • 6.3.2 United States Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2021-2032)
  • 7.2 Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2021-2032)
  • 7.3 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country
    • 7.3.1 Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 7.3.3 France Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region
    • 8.3.1 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Region (2021-2032)
    • 8.3.2 China Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 8.3.5 India Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2021-2032)
  • 9.2 South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2021-2032)
  • 9.3 South America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country
    • 9.3.1 South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country
    • 10.3.1 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Small Molecule Targeted Drugs for Allergic Diseases Market Drivers
  • 11.2 Small Molecule Targeted Drugs for Allergic Diseases Market Restraints
  • 11.3 Small Molecule Targeted Drugs for Allergic Diseases Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Small Molecule Targeted Drugs for Allergic Diseases Industry Chain
  • 12.2 Small Molecule Targeted Drugs for Allergic Diseases Upstream Analysis
  • 12.3 Small Molecule Targeted Drugs for Allergic Diseases Midstream Analysis
  • 12.4 Small Molecule Targeted Drugs for Allergic Diseases Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Small Molecule Targeted Drugs for Allergic Diseases market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Small molecule targeted drugs include JAK inhibitors and TYK2 inhibitors, which exert immunomodulatory effects by blocking the JAK/STAT pathway. Compared with traditional anti-allergic drugs, targeted drugs have better efficacy in severe or drug-resistant patients, and the drugs themselves are safer, and have gradually become the mainstream trend in the development of anti-allergic drugs.
    This report is a detailed and comprehensive analysis for global Small Molecule Targeted Drugs for Allergic Diseases market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Small Molecule Targeted Drugs for Allergic Diseases market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Small Molecule Targeted Drugs for Allergic Diseases market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Small Molecule Targeted Drugs for Allergic Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Small Molecule Targeted Drugs for Allergic Diseases market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Small Molecule Targeted Drugs for Allergic Diseases
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Small Molecule Targeted Drugs for Allergic Diseases market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Pfizer, Novartis, Eli Lilly and Company, LEO Pharma, AstraZeneca, Incyte, Jiangsu Hengrui Pharmaceuticals, Suzhou Zelgen Biopharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Small Molecule Targeted Drugs for Allergic Diseases market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    JAK
    TYK2
    Market segment by Application
    Atopic Dermatitis
    Asthma
    Others
    Market segment by players, this report covers
    AbbVie
    Pfizer
    Novartis
    Eli Lilly and Company
    LEO Pharma
    AstraZeneca
    Incyte
    Jiangsu Hengrui Pharmaceuticals
    Suzhou Zelgen Biopharmaceuticals
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Small Molecule Targeted Drugs for Allergic Diseases product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Small Molecule Targeted Drugs for Allergic Diseases, with revenue, gross margin, and global market share of Small Molecule Targeted Drugs for Allergic Diseases from 2021 to 2026.
    Chapter 3, the Small Molecule Targeted Drugs for Allergic Diseases competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Small Molecule Targeted Drugs for Allergic Diseases market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Small Molecule Targeted Drugs for Allergic Diseases.
    Chapter 13, to describe Small Molecule Targeted Drugs for Allergic Diseases research findings and conclusion.

    Buy now